🔴 Aytu BioScience is trading 7.04% down in pre-market with no clear catalyst identified

Aytu BioScience is trading 7.04% down at $1.85 after closing at $1.99 on September 15, 2026, with no clear company-specific catalyst identified.

• No verified overnight company-specific announcement, earnings release, FDA action, or regulatory filing has been identified; available coverage describes after-hours weakness as lacking a clear catalyst.
• Pre-market weakness appears isolated rather than broad-market driven; broader U.S. futures were modestly higher on September 16, 2026.
• Next earnings report is expected September 29, 2026.